DS
ELOX

David Shaw’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

David Shaw’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-532
Closed -$6K – 5733
2022
Q2 		$6K Hold
532
– – ﹤0.01% 5217
2022
Q1 		$12K Hold
532
– – ﹤0.01% 5404
2021
Q4 		$15K Sell
532
-1,060
-67% -$46.2K ﹤0.01% 5316
2021
Q3 		$104K Buy
+1,592
New +$98.2K ﹤0.01% 4714

Other funds holding ELOX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $284M AUM 12.01% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $8.04B AUM 44.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

David Shaw's ELOX Position: Q3 2022 in Review

David Shaw sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q3 2022, closing a stake of 532 shares — an estimated $6K sold.

David Shaw first reported a position in ELOX in Q3 2021 and held it in 4 quarters. The position peaked at $104K in Q3 2021. 30 funds tracked by Wall St. Rank hold ELOX as of Q3 2022.

  • David Shaw reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • David Shaw sold 532 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q3 2022, an estimated $6K.
  • David Shaw first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q3 2021 and held it in 4 quarters.
  • David Shaw's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $104K in Q3 2021.
  • 30 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q3 2022.

Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.